Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Natera Inc (NTRA)

Natera Inc (NTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,324,126
  • Shares Outstanding, K 122,803
  • Annual Sales, $ 1,083 M
  • Annual Income, $ -434,800 K
  • 60-Month Beta 1.38
  • Price/Sales 12.17
  • Price/Cash Flow N/A
  • Price/Book 16.24
Trade NTRA with:

Options Overview Details

View History
  • Implied Volatility 37.63% ( +0.73%)
  • Historical Volatility 41.26%
  • IV Percentile 0%
  • IV Rank 1.75%
  • IV High 78.33% on 11/08/23
  • IV Low 36.91% on 05/16/24
  • Put/Call Vol Ratio 1.20
  • Today's Volume 207
  • Volume Avg (30-Day) 598
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 8,015
  • Open Int (30-Day) 5,452

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.68
  • Number of Estimates 5
  • High Estimate -0.58
  • Low Estimate -0.79
  • Prior Year -0.97
  • Growth Rate Est. (year over year) +29.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.13 +28.06%
on 04/19/24
108.75 -2.11%
on 05/17/24
+16.13 (+17.86%)
since 04/17/24
3-Month
68.03 +56.49%
on 02/20/24
108.75 -2.11%
on 05/17/24
+36.45 (+52.06%)
since 02/16/24
52-Week
36.90 +188.51%
on 10/30/23
108.75 -2.11%
on 05/17/24
+56.82 (+114.46%)
since 05/17/23

Most Recent Stories

More News
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

Stocks that traded heavily or had substantial price changes on Friday: Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall

DBX : 23.73 (-0.96%)
PGNY : 28.09 (+1.96%)
NTRA : 106.46 (-1.88%)
MTD : 1,522.75 (-0.51%)
AKAM : 95.21 (-1.71%)
COLL : 32.47 (-3.56%)
Natera: Q1 Earnings Snapshot

Natera: Q1 Earnings Snapshot

NTRA : 106.46 (-1.88%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
BMY : 44.03 (-0.18%)
TMO : 595.30 (-0.31%)
NTRA : 106.46 (-1.88%)
NEO : 14.80 (-1.27%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
BMY : 44.03 (-0.18%)
TMO : 595.30 (-0.31%)
NTRA : 106.46 (-1.88%)
NEO : 14.80 (-1.27%)
Macy's, SolarEdge rise; Archer Daniels Midland, Sunoco fall, Monday, 1/22/2024

Stocks that traded heavily or had substantial price changes on Monday: Macy’s, SolarEdge rise; Archer Daniels Midland, Sunoco fall

NWBI : 11.40 (+0.62%)
NTRA : 106.46 (-1.88%)
GILD : 67.72 (-0.21%)
SUN : 53.82 (+1.07%)
SEDG : 48.41 (-4.18%)
ZS : 178.86 (-0.25%)
M : 19.49 (-0.66%)
ADM : 61.62 (+0.05%)
Stocks End Lower as U.S. Economic Strength Dampens Fed Rate-Cut Expectations

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.56%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 5,303.27 (+0.12%)
SPY : 529.45 (+0.14%)
$DOWI : 40,003.59 (+0.34%)
DIA : 399.95 (+0.33%)
$IUXX : 18,546.23 (-0.06%)
QQQ : 451.76 (-0.05%)
BA : 184.95 (+1.09%)
CRWD : 345.93 (+2.03%)
INTC : 31.83 (-0.62%)
MCHP : 94.33 (+0.10%)
ON : 73.17 (+0.23%)
NXPI : 267.72 (-0.70%)
S&P Futures Slip Ahead of Key U.S. Retail Sales Data, Chinese Data Disappoints

March S&P 500 E-Mini futures (ESH24) are trending down -0.42% this morning as investors digested weak economic data from China while also gearing up for crucial U.S. retail sales data.

BA : 184.95 (+1.09%)
MS : 100.22 (+0.64%)
SAVE : 3.80 (-1.30%)
AMD : 164.47 (+1.14%)
WDC : 72.10 (-2.70%)
PLD : 111.50 (+0.64%)
SCHW : 78.78 (+0.95%)
USB : 41.43 (-0.53%)
KMI : 19.70 (+0.51%)
AA : 41.22 (+2.67%)
NTRA : 106.46 (-1.88%)
PI : 173.40 (+2.23%)
Natera: Q3 Earnings Snapshot

Natera: Q3 Earnings Snapshot

NTRA : 106.46 (-1.88%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
GH : 25.36 (-3.35%)
NTRA : 106.46 (-1.88%)
DGX : 144.34 (+1.34%)
NEO : 14.80 (-1.27%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...

TELO.VN : 0.180 (+5.88%)
TDSGF : 0.1227 (+1.32%)
GH : 25.36 (-3.35%)
NTRA : 106.46 (-1.88%)
DGX : 144.34 (+1.34%)
NEO : 14.80 (-1.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 110.36
2nd Resistance Point 109.55
1st Resistance Point 108.01
Last Price 106.46
1st Support Level 105.66
2nd Support Level 104.85
3rd Support Level 103.31

See More

52-Week High 108.75
Last Price 106.46
Fibonacci 61.8% 81.30
Fibonacci 50% 72.82
Fibonacci 38.2% 64.35
52-Week Low 36.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar